Capital Research Global Investors Applied Molecular Transport Inc. Transaction History

Capital Research Global Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$13.23 - $26.05 $15.3 Million - $30.1 Million	-1,154,180 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$25.87 - $46.61 $71.8 Million - $129 Million	-2,776,176 Reduced 70.63%	1,154,180 $29.9 Million
Q2 2021 Aug 16, 2021	BUY	$39.76 - $64.31 $45.8 Million - $74.1 Million	1,151,525 Added 41.44%	3,930,356 $180 Million
Q1 2021 May 14, 2021	SELL	$30.5 - $74.14 $728,004 - $1.77 Million	-23,869 Reduced 0.85%	2,778,831 $122 Million
Q2 2020 Aug 14, 2020	BUY	$17.98 - $28.0 $50.4 Million - $78.5 Million	2,802,700 New	2,802,700 $70.5 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.